European Neuropsychopharmacology

Print ISSN
0924-977X
Electronic ISSN
1873-7862
Impact factor
4.201
Publisher
Sciencedirect
URL
http://www.sciencedirect.com/science/journal/0924977X
Usage rank
2775
Article count
1650
Free count
6
Free percentage
0.00363636
PDFs via platforms
Sciencedirect, Gale, Ingenta, CSA, Rcgp, and Proquest

  1. Contents
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):OBC (2015)

  2. Contents continued
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):V (2015)

  3. ECNP Calendar of Events
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):I (2015)

  4. Editorial Board
    Author(s) unavailable

    European Neuropsychopharmacology 25(10):IFC (2015)

  5. Editorial Board
    Author(s) unavailable

    European Neuropsychopharmacology 25(9):IFC (2015)

  6. P.4.b.010 Fear conditioning and BDNF levels and genotype in obsessive-compulsive disorder patients pre and post treatment with sertraline: preliminary results

    European Neuropsychopharmacology 25:S562 (2015)

  7. P.4.b.005 Changes in high frequency oscillations (HFOs) in anxiety disorders: a pilot study

    European Neuropsychopharmacology 25:S559 (2015)

  8. P.4.c.004 Adult neuroplasticity as a pathological trigger of recurrence in depression

    European Neuropsychopharmacology 25:S564 (2015)

  9. P.4.b.009 The white ‘matter’ in obsessive compulsive disorder: effect of pharmacological treatment and symptom dimensions models

    European Neuropsychopharmacology 25:S561 (2015)

  10. P.3.f.018 Evolution of anhedonia and depressive symptoms in Romanian outpatients diagnosed with major depressive episode and treated with agomelatine

    European Neuropsychopharmacology 25:S545 (2015)

  11. P.4.b.003 High trait anxiety promotes memory for threat-congruent faces under threat of unpredictable shock

    European Neuropsychopharmacology 25:S558 (2015)

  12. P.4.a.002 Anxiolytic effects of an orally available nove TSPO antagonist in rodents

    European Neuropsychopharmacology 25:S553 (2015)

  13. P.3.f.023 Brief cognitive battery to monitor stable outpatients with schizophrenia

    European Neuropsychopharmacology 25:S549 (2015)

  14. P.3.f.016 Initial medical work-up in first episode psychosis

    European Neuropsychopharmacology 25:S544 (2015)

  15. C.13.03 A primary care perspective on the management of patient cases of MDD and cognitive dysfunction

    European Neuropsychopharmacology 25:S674 (2015)

  16. Keyword Index
    Author(s) unavailable

    European Neuropsychopharmacology 25:S703 (2015)

  17. P.2.f.026 Adjunctive brexpiprazole (OPC-34712) in young patients with major depressive disorder who are working or at school: an exploratory study

    European Neuropsychopharmacology 25:S449 (2015)

  18. P3.b.004 COMT × DRD2 epistasis modulates a putative emotional connectomic intermediate phenotype for schizophrenia

    European Neuropsychopharmacology 25:S464 (2015)

  19. P.3.b.001 Exploring shared and variant alterations in brain function between schizophrenia and bipolar disorder using resting-state fMRI

    European Neuropsychopharmacology 25:S462 (2015)

  20. P.2.f.024 Adequacy of antidepressant treatment in primary care: preliminary results after implementing a computerised guide for major depression

    European Neuropsychopharmacology 25:S448 (2015)